Loewy Caroline M 4
4 · PhaseBio Pharmaceuticals Inc · Filed May 19, 2023
Insider Transaction Report
Form 4
Loewy Caroline M
Director
Transactions
- Exercise/Conversion
Common Stock
2023-05-19+3,750→ 3,750 total - Exercise/Conversion
Restricted Stock Units
2023-05-19−3,750→ 0 total→ Common Stock (3,750 underlying)
Footnotes (2)
- [F1]Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of PhaseBio Pharmaceuticals, Inc. common stock.
- [F2]The RSUs vested and were delivered to the Reporting Person on the one-year anniversary of the grant date, subject to the Reporting Person's continuous service through such date.